Clik here to view.
2026 ASCO Meeting Review: Albert Craig Lockhart MD, MHS
Hello ECAN Community, As a Board Member of ECAN, I always look forward to the American Society of Clinical Oncology (ASCO) annual meeting in Chicago. It’s the world’s stage for the most impactful new...
View ArticleClik here to view.
U.S. Senate Passes Historic Gerald E. Connolly Esophageal Cancer Awareness Act
First stand-alone federal legislation focused exclusively on esophageal cancer heads to President Trump’s desk Washington, DC — May 22, 2026 — In one of his final official acts before esophageal cancer...
View ArticleClik here to view.
April is Esophageal Cancer Awareness Month!
FOR IMMEDIATE RELEASE April is Esophageal Cancer Awareness Month: Join the Movement to Save Lives Through Early Detection and Action Washington, D.C. — April 2026 — April marks Esophageal Cancer...
View ArticleClik here to view.
ECAN Board Names Alyssa O’Driscoll as New Executive Director
Experienced Nonprofit Leader Succeeds Retiring Founder Mindy Mintz Mordecai (BALTIMORE, MD—February 11, 2026) — The Esophageal Cancer Action Network (ECAN) announced today that its Board of Directors...
View ArticleClik here to view.
Webinar: Immunotherapy for Patients with Operable Esophageal and GE Junction...
For more than four years, immunotherapy has been available as a first-line treatment for patients with Advanced and Metastatic Esophageal Cancer who are not eligible for surgery. In 2021, patients who...
View ArticleClik here to view.
Possible New Weapon to Fight Esophageal Cancer Magnifies Impact of Radiation...
Late-stage clinical biotechnology company Nanobiotix announced promising first results of a Phase I study of the nanoradioenhancer NBTXR3 for patients with locally advanced Esophageal Adenocarcinoma....
View ArticleClik here to view.
Mindy Mintz Mordecai, Founder, President, and CEO of ECAN to Retire
Mindy Mintz Mordecai, Founder, President, and CEO of the Esophageal Cancer Action Network since 2009, will retire at the end of 2025. Read her letter to the community. The Esophageal Cancer Action...
View ArticleClik here to view.
A Message from our Founder & CEO
ECAN has never been a job for me. It’s been my passion. Leading this movement to save lives has been one of the greatest privileges of my life. Only your generous support and trust made that possible –...
View ArticleHalf Off All ECAN Merch – Free Shipping on $100+ orders
ECAN is moving and we want to lighten our load – that’s why EVERYTHING is at least 50% off at our BuyPeriwinkle Store. But hurry … this sale only lasts two weeks (through 7/23). Shipping is FREE with...
View ArticleClik here to view.
Historic Bill Passed by U.S. House of Representatives
In his final official act before Esophageal Cancer cut short his life, Congressman Gerald Connolly (D-Va) made history by introducing a bill focused exclusively on Esophageal Cancer. No legislation...
View ArticleClik here to view.
A Message from our Founder
“Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has.” ~ Margaret Mead 17 years. It is hard to believe that much time has...
View ArticleApril is Esophageal Cancer Awareness Month!
ECAN is proud to have started Esophageal Cancer Awareness Month in 2009. We’ve been thrilled ever since by all of the other organizations, companies, and individuals that have made the observance of EC...
View ArticleClik here to view.
Art Journaling for Patients & Caregivers
.fusion-body .fusion-builder-column-0{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-column-0 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px...
View ArticleClik here to view.
Learn about the Latest Therapy Approved by the FDA for Gastroesophageal...
A new type of therapy has been approved by the FDA for patients with Gastroesophageal Adenocarcinoma. Learn more. On Monday, March 3, 2025, at 2 p.m., ECAN will host a free webinar to discuss...
View ArticleMore than 75% of Oncologists in some Communities are Not Ordering Biomarker...
Needed Biomarker Testing Not Happening for Patients with Advanced Gastroesophageal Cancer in Many Community Practices. In a Project with Five Community-Based Oncology Practices throughout the US, a...
View ArticleClik here to view.
Find out about the Latest in Advancements for Esophageal Cancer Treatment
ECAN will host a free webinar on Tuesday, March 4, 2025 at 2:15 pm Eastern time to explore the latest in Esophageal Cancer treatment options. Dr. Craig Lockhart, chair of ECAN’s Medical Research and...
View ArticleClik here to view.
FDA approves New Therapy Aimed at a New Target in Esophageal Cancer at the GE...
The Food and Drug Administration (FDA) has approved Zolbetuximab (Vyloy) as a first-line treatment for patients with advanced HER2* negative Esophageal Cancer found at the junction of the stomach and...
View ArticleStudy finds Regimen that doesn’t include Radiation is Better than current...
A German study finds a 30% reduction in the risk of death among Esophageal Adenocarcinoma patients who were treated with perioperative chemotherapy when compared with chemoradiation. The phase 3...
View ArticleFDA Advisory Panel votes to limit some EC patients’ access to immunotherapy
In 2021, Esophageal Cancer patients and advocates celebrated the Food and Drug Administration’s approval of immunotherapies for patients with advanced Gastroesophageal Cancer, Esophageal...
View ArticleClik here to view.
A Father’s Day Challenge: Raise $5,000 and every dollar will be matched
This day is meant to honor those special men who have made a significant difference in our lives. Now, a generous donor is making it possible for you to honor that man in your life with a truly...
View Article
